Pegylation of interferon alfa: structural and pharmacokinetic properties.
about
Antiviral drugs for viruses other than human immunodeficiency virusAdvances in PEGylation of important biotech molecules: delivery aspectsPharmaceutical and toxicological properties of engineered nanomaterials for drug deliveryEvaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.Treating viral hepatitis C: efficacy, side effects, and complications.Pharmacokinetic consequences of pegylation.Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.Novel delivery systems for interferons.Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.Magnetic Resonance and Ultrastructural Characterization of PEGylation-associated Vacuolation in Nonclinical Models.Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
P2860
Q24635330-F20B5F4E-500F-467D-8038-7F57F70CDF6DQ28277255-C599587A-8CC9-4D41-8DCA-32FBF9AC91BBQ28396383-2EC3B7F0-038D-454B-831B-7AB9374E5E0FQ35604803-71FAA037-CCC5-4ADB-BE84-57D7D91A1819Q36564615-ED77DCC4-734E-455B-9608-151B985ED953Q36604526-8D9086D1-2975-4E86-958F-AF897F47501EQ36920320-107D5B86-57F4-42C5-B624-BEB3DECE16C8Q36937971-2646BE1C-65F6-4EE9-B5BF-80E00D52ABEFQ38729299-8CD677E5-6B26-42D8-A03E-CBAE8E6492E6Q46341302-33C11BF3-2A0F-4FBE-932F-D890C40E507CQ46929739-94984FB0-BCED-4B07-90CC-00240F3DC95C
P2860
Pegylation of interferon alfa: structural and pharmacokinetic properties.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@ast
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@en
type
label
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@ast
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@en
prefLabel
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@ast
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@en
P356
P1476
Pegylation of interferon alfa: structural and pharmacokinetic properties.
@en
P2093
Simon C J Pedder
P356
10.1055/S-2003-41635
P478
23 Suppl 1
P577
2003-01-01T00:00:00Z